SRRK · earnings call history
Scholar Rock Q2 FY26 — Apitegromab BLA Progresses with Dual Fill/Finish Paths Towards September 30 PDUFA
Read the briefScholar Rock Q1 FY26 — Apitegromab BLA Accepted with Dual Fill-Finish Facilities
Read the briefScholar Rock Q4 FY25 — Apitegromab Regulatory Progress and Pipeline Advancement
Read the briefBrowse all US companies on the earnings-call register.